This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Summary
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Isologic Innovative Radiopharmaceuticals |
18F-FLUDEOXYGLUCOSE (18F-FDG) |
DIN 02328739 |
Solution |
Fludeoxyglucose 18F 7400 MBq / mL |
L06DEC22-4 |
Issue
Product sterility may be compromised in the affected lot.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Healthcare Establishments
Details
Isologic Innovative Radiopharmaceuticals Inc.
1855 32e Avenue,
Lachine, QC, H8T 3J1, Canada
Get notified
Receive notifications for new and updated recalls and alerts by category.